XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash Flows from Operating Activities:    
Net income $ 10,465 $ 8,947
Adjustments to reconcile net income to net cash provided by operating activities:    
(Reversal of) provision for credit losses on loans (485) (2,929)
(Reversal of) provision for credit losses on unfunded loan commitments (318) (590)
Noncash contribution expense to employee stock ownership plan 417 332
Noncash director compensation expense 244 162
Stock-based compensation expense 237 615
Amortization of core deposit intangible 380 204
Amortization of investment security premiums, net of accretion of discounts 2,497 685
Accretion of premiums (discounts) on acquired loans 115 (33)
Accretion of discount on subordinated debenture 0 1,347
Net change in deferred loan origination costs/fees (1,591) 2,658
Depreciation and amortization 452 459
Earnings on bank-owned life insurance policies (413) (257)
Net changes in interest receivable and other assets 4,648 2,901
Net changes in interest payable and other liabilities (5,169) (2,065)
Total adjustments 1,014 3,489
Net cash provided by operating activities 11,479 12,436
Cash Flows from Investing Activities:    
Purchase of held-to-maturity securities (95,932) (41,607)
Purchase of available-for-sale securities (243,459) (151,828)
Proceeds from paydowns/maturities of held-to-maturity securities 5,067 8,600
Proceeds from paydowns/maturities of available-for-sale securities 42,966 16,060
Loan principal collected, net of originations 54,524  
Loan principal collected, net of originations   (36,543)
Cash receipts from bank-owned life insurance policies 350 0
Purchase of premises and equipment (130) (144)
Cash paid for low income housing tax credit investment (4) (313)
Net cash used in investing activities (236,618) (205,775)
Cash Flows from Financing Activities:    
Net increase in deposits 52,792 151,950
Proceeds from stock options exercised 739 38
Restricted stock surrendered for tax withholdings upon vesting (29) (156)
Proceeds from stock issued under employee and director stock purchase plans 0 46
Stock repurchased, including commissions (1,250) (8,792)
Repayment of subordinated debenture including execution costs 0 (4,126)
Repayment of finance lease obligations (31) (28)
Cash dividends paid on common stock (3,822) (3,094)
Net cash provided by financing activities 48,399 135,838
Net decrease in cash, cash equivalents and restricted cash (176,740) (57,501)
Cash, cash equivalents and restricted cash at beginning of period 347,641 200,320
Cash, cash equivalents and restricted cash at end of period 170,901 142,819
Supplemental disclosure of cash flow information:    
Cash paid in interest 588 492
Cash paid in income taxes 0 0
Supplemental disclosure of noncash investing and financing activities:    
Change in net unrealized gain or loss on available-for-sale securities (38,228) (9,092)
Securities transferred from available-for-sale to held-to-maturity, at fair value 357,482 0
Amortization of net unrealized loss on available-for-sale securities transferred to held-to-maturity 144 143
Purchase of investment security not yet settled 0 10,000
Stock issued to employee stock ownership plan 417 332
Stock issued in payment of director fees 193 117
Repurchase of stock not yet settled 0 132
Restricted cash [1] $ 930 $ 1,930
[1] Restricted cash includes reserve requirements held with the Federal Reserve Bank of San Francisco and other cash pledged. In response to the COVID-19 pandemic, the Federal Reserve reduced the reserve requirement ratios to zero percent effective March 26, 2020.